NASDAQ: HSIC
Henry Schein Inc Stock

$79.92-0.05 (-0.06%)
Updated Jun 18, 2026
HSIC Price
$79.92
Fair Value Price
$67.10
Market Cap
$9.10B
52 Week Low
$61.95
52 Week High
$89.29
P/E
24x
P/B
2.79x
P/S
0.62x
PEG
0.93x
Dividend Yield
N/A
Revenue
$13.38B
Earnings
$395.00M
Gross Margin
31.2%
Operating Margin
5.07%
Profit Margin
3%
Debt to Equity
1.99
Operating Cash Flow
$578M
Beta
0.62
Next Earnings
Aug 4, 2026
Ex-Dividend
N/A
Next Dividend
N/A

HSIC Overview

Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine HSIC's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Distribution

Industry Rating
A
HSIC
Ranked
#2 of 6

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$221.77B
$750.63B
$3.23C
View Top Medical Distribution Stocks

Be the first to know about important HSIC news, forecast changes, insider trades & much more!

HSIC News

Overview

Due Diligence Score

Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HSIC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HSIC ($79.92) is overvalued by 19.1% relative to our estimate of its Fair Value price of $67.10 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
HSIC ($79.92) is not significantly undervalued (19.1%) relative to our estimate of its Fair Value price of $67.10 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
HSIC ($79.92) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more HSIC due diligence checks available for Premium users.

Valuation

HSIC fair value

Fair Value of HSIC stock based on Discounted Cash Flow (DCF)

Price
$79.92
Fair Value
$67.10
Overvalued by
19.10%
HSIC ($79.92) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HSIC ($79.92) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HSIC ($79.92) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HSIC price to earnings (PE)

For valuing profitable companies with steady earnings

Company
24x
Industry
23.43x
Market
9.47x
HSIC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HSIC is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

HSIC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.79x
Industry
146.95x
HSIC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HSIC price to earnings growth (PEG)

For valuing profitable companies with growth potential

HSIC is good value based... subscribe to Premium to read more.
PEG Value Valuation

HSIC's financial health

Profit margin

Revenue
$3.4B
Net Income
$107.0M
Profit Margin
3.2%
HSIC's Earnings (EBIT) of $678.00M... subscribe to Premium to read more.
Interest Coverage Financials
HSIC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$11.3B
Liabilities
$6.5B
Debt to equity
1.99
HSIC's short-term assets ($4.50B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HSIC's short-term assets ($4.50B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HSIC's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
HSIC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$97.0M
Investing
-$63.0M
Financing
$120.0M
HSIC's operating cash flow ($578.00M)... subscribe to Premium to read more.
Debt Coverage Financials

HSIC vs Medical Distribution Stocks

TickerZen RatingMarket Cap1d %P/EP/B
HSICB$9.10B-0.06%24.00x2.79x
AHGD$1.15B+8.94%-2.77x5.78x
ACHC$247.37M+2.22%-0.23x-0.53x
FOCL$180.29M-1.84%-4.93x15.17x
COSM$11.59M-11.98%-0.33x0.58x

Henry Schein Stock FAQ

What is Henry Schein's quote symbol?

(NASDAQ: HSIC) Henry Schein trades on the NASDAQ under the ticker symbol HSIC. Henry Schein stock quotes can also be displayed as NASDAQ: HSIC.

If you're new to stock investing, here's how to buy Henry Schein stock.

What is the 52 week high and low for Henry Schein (NASDAQ: HSIC)?

(NASDAQ: HSIC) Henry Schein's 52-week high was $89.29, and its 52-week low was $61.95. It is currently -10.49% from its 52-week high and 29.02% from its 52-week low.

How much is Henry Schein stock worth today?

(NASDAQ: HSIC) Henry Schein currently has 113,916,757 outstanding shares. With Henry Schein stock trading at $79.92 per share, the total value of Henry Schein stock (market capitalization) is $9.10B.

Henry Schein stock was originally listed at a price of $8.75 in Dec 31, 1997. If you had invested in Henry Schein stock at $8.75, your return over the last 28 years would have been 813.37%, for an annualized return of 8.22% (not including any dividends or dividend reinvestments).

How much is Henry Schein's stock price per share?

(NASDAQ: HSIC) Henry Schein stock price per share is $79.92 today (as of Jun 18, 2026).

What is Henry Schein's Market Cap?

(NASDAQ: HSIC) Henry Schein's market cap is $9.10B, as of Jun 22, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Henry Schein's market cap is calculated by multiplying HSIC's current stock price of $79.92 by HSIC's total outstanding shares of 113,916,757.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.